Siu Yin Francisca  Wong

Ms. Siu Yin Francisca Wong


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SWSiu Yin Francisca Wong
Siu Yin Francisca Wong
BCBarbara P. Chan
Barbara P. Chan
ALAmy Cheuk Yin Lo
Amy Cheuk Yin Lo
There is a pressing need for long-term neuroprotective and neuroregenerative therapies to promote full function recovery of injuries in the human nervous system resulting from trauma, stroke or degenerative diseases. Although cell-based therapies are promising in supporting repair and regeneration, direct introduction to the injury site is plagued by problems such as low transplanted cell survival rate, limited graft integration, immunorejection, and tumor formation. Neural tissue engineering offers an integrative and multifaceted approach to tackle these complex neurological disorders. Synergistic therapeutic effects can be obtained from combining customized biomaterial scaffolds with cell-based therapies. Current scaffold-facilitated cell transplantation strategies aim to achieve structural and functional rescue via offering a three-dimensional permissive and instructive environment for sustainable neuroactive factor production for prolonged periods and/or cell replacement at the target site. In this review, we intend to highlight important considerations in biomaterial selection and to review major biodegradable or non-biodegradable scaffolds used for cell transplantation to the central and peripheral nervous system in preclinical and clinical trials. Expanded knowledge in biomaterial properties and their prolonged interaction with transplanted and host cells have greatly expanded the possibilities for designing suitable carrier systems and the potential of cell therapies in the nervous system.

6 November 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SKSum Sum Kwok
Sum Sum Kwok
SWSiu Yin Francisca Wong
Siu Yin Francisca Wong
KSKendrick Co Shih
Kendrick Co Shih
Yau Kei ChanYau Kei Chan
Yau Kei Chan
YBYashan Bu
Yashan Bu
VJVishal Jhanji
Vishal Jhanji
(1) Objective: To study the anti-fibrotic effects of Lycium barbarum polysaccharides (LBP) on corneal stromal fibroblasts and assess LBP’s effect on cell viability. (2) Methods: Primary human corneal keratocytes of passage 3 to 6 were used for all experiments. Cells are pretreated with LBP solution for 24 h and then transforming growth factor beta 1 (TGFβ1) for 48 h and collected for experiments. Fibrotic protein analysis was performed using immunofluorescence and Western blot. The effect of LBP on cell viability was assessed using the MTS assay. (3) Results: LBP significantly reduced the expression of fibrotic proteins, including α-SMA and extracellular matrix proteins (collagen type I and III). LBP significantly decreased the viability of myofibroblasts but not the fibroblasts. Conclusions: In this study, LBP was effective in the prevention of fibrosis gene expression. Further studies to assess the underlying mechanism and pharmacological properties will facilitate the formation of a topical LBP solution for in vivo studies.

19 December 2025 in Tropical Medicine and Health
Verified
Journal Article
Open access
PDF file
SWSiu Yin Francisca Wong
Siu Yin Francisca Wong
FMFukushi Morishita
Fukushi Morishita
KOKyung Hyun Oh
Kyung Hyun Oh
HTHuong Thi Giang Tran
Huong Thi Giang Tran
RYRajendra-Prasad Yadav
Rajendra-Prasad Yadav
Background: Migration significantly influences tuberculosis (TB) epidemiology in the Western Pacific Region (WPR), posing challenges to its control and elimination. This study examines the burden of TB among foreign-born individuals at regional and national levels in the WPR. Methods: Using data from the WHO Global TB Database and the United Nations’ International Migrant Stock dataset, we analysed the number and proportion of foreign-born TB case notifications across the region from 2008 to 2023. We also compared estimated TB incidence among international migrants with regional and national averages in WPR destinations. Results: Foreign-born TB notifications increased from 5,639 in 2008 to 10,056 in 2023, with trends varying across the WPR. Malaysia (40.4%), Japan (16.0%), and Australia (12.7%) accounted for the largest caseloads in 2023. Between 2021 and 2023, foreign-born TB cases represented 0.8% of total case notifications in the region, with Australia (89.9%), and New Zealand (86.5%) reporting the highest proportions. As of 2020, international migrants in the WPR (24.8 million, 77.9% of whom originated from high-burden countries) had an estimated TB incidence rate of 130 per 100,000, exceeding national averages in many countries and areas. Conclusions: Significant disparities remain in the foreign-born TB burden across the WPR. Strengthening surveillance, improving data comparability, and enhancing cross-border collaboration through migrant-sensitive approaches may help address existing gaps and support progress towards the End TB targets.